Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas
NCT02503423
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
253
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumors
Lymphoma
Interventions
DRUG:
ASTX660
Sponsor
Taiho Oncology, Inc.